論文業績

2019年

  1. Uchida A, Kidokoro K, Sogawa Y, Itano S, Nagasu H, Satoh M, Sasaki T, Kashihara N. 5-aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury. Nephrology (Carlton). 24(1):28-38, 2019
  2. Mishima E, Haruna Y, Arima H. Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials. Hypertens Res. 42(4):469-482, 2019
  3. Nagasu A, Mukai T, Iseki M, Kawahara K, Tsuji S, Nagasu H, Ueki Y, Ishihara K, Kashihara N, Morita Y. Sh3bp2 Gain-Of-Function Mutation Ameliorates Lupus Phenotypes in B6.MRL-Faslpr Mice. Cells. 8(5) pii:E402, 2019
  4. Satoh M, Maruhashi T, Yoshida Y, Shibata H. Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism. Hypertens Res. 42(6):817-824, 2019
  5. Ito M, Ishimitsu T, Ichihara A, Itoh H, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nakamura S, Nishiyama A, Node K, Hasebe N, Higaki J, Miura K, Rakugi H, Tamura K, Kawano Y, Yatabe T, Ohya Y, Ito S. JSH Statement: Kyoto declaration on hypertension research in Asia. Hypertens Res. 42(6):759-760, 2019
  6. Nagasu H, Sogawa Y, Kidokoro K, Itano S, Yamamoto T, Satoh M, Sasaki T, Suzuki T, Yamamoto M, Wigley WC, Proksch JW, Meyer CJ, Kashihara N. Bardoxolone methyl analog attenuates proteinuria-induced tubular damage by modulating mitochondrial function. FASEB J. fj201900217R. doi: 10.1096/fj.201900217R, 2019

2018年

  1. Hoshino J, Nagai K, Kai H, Saito C, Ito Y, Asahi K, Kondo M, Iseki K, Iseki C, Okada H, Kashihara N, Narita I, Wada T, Combe C, Pisoni RL, Robinson BM, Yamagata K. A nationwide prospective cohort study of patients with advanced chronic kidney disease in Japan: The Reach-J CKD cohort study. Clin Exp Nephrol. 22(2):309-317, 2018
  2. Kanda E, Usui T, Kashihara N, Iseki C, Iseki K, Nangaku M. Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study. Clin Exp Nephrol. 22(2):318-327, 2018
  3. Porter RS, Murata-Nakamura Y, Nagasu H, Kim HG, Iwase S. Transcriptome Analysis Revealed Impaired cAMP Responsiveness in PHF21A-Deficient Human Cells. Neuroscience. 370(2):170-180, 2018
  4. Komatsu H, Fujimoto S, Maruyama S, Mukoyama M, Sugiyama H, Tsuruya K, Satoh H, Soma J, Yano J, Itano S, Nishino T, Sato T, Narita I, Yokoyama H. Distinict characteristics and outcomes in elderly-onset IgA vasculitis(Henoch-Schönlein purpura) with nephritis: Nationwide cohort study of data from the Japan Renal Biopsy Registry (J-RBR). PLoS One. 13(5):e0196955, 2018
  5. Doi K, Nishida O, Shigematsu T, Sadahiro T, Itami N, Iseki K, Yuzawa Y, Okada H, Koya D, Kiyomoto H, Shibagaki Y, Matsuda K, Kato A, Hayashi T, Ogawa T, Tsukamoto T, Noiri E, Negi S, Kamei K, Kitayama H, Kashihara N, Moriyama T, Terada Y; Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee. The Japanese clinical practice guideline for acute kidney injury 2016. Clin Exp Nephrol. 22(5):985-1045, 2018
  6. Kanda E, Kashihara N, Matsushita K, Usui T, Okada H, Iseki K, Mikami K, Tanaka T, Wada T, Watada H, Ueki K, Nangaku M; Research Working Group for Establishing Guidelines for Clinical Evaluation of Chronic Kidney Disease. Guidelines for clinical evaluation of chronic kidney disease : AMED research on regulatory science of pharmaceuticals and medical devices. Clin Exp Nephrol. 22(6):1446-1475, 2018
  7. Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y. Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study. Clin Exp Nephrol. 22(6):1266-1280, 2018
  8. Usui T, Kanda E, Iseki C, Iseki K, Kashihara N, Nangaku M. Observation period for changes in proteinuria and risk prediction of end-stage renal disease in general population. Nephrology (Carlton). 23(9):821-829, 2018
  9. Sogawa Y, Nagasu H, Itano S, Kidokoro K, Taniguchi S, Takahashi M, Kadoya H, Satoh M, Sasaki T, Kashihara N. The eNOS-NO pathway attenuates kidney dysfunction via suppression of inflammasome activation in aldosterone-induced renal injury model mice. PLoS One. 13(10):e0203823, 2018
  10. Node K, Kishi T, Tanaka A, Itoh H, Rakugi H, Ohya Y, Miura K, Okamura T, Ishimitsu T, Ichihara A, Ito M, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nakamura S, Nishiyama A, Hasebe N, Higaki J, Tamura K, Kawano Y, Yatabe T, Ito S; JSH Future Plan Working Group and Executive Board Members. The Japanese Society of Hypertension-Digest of plan for the future. Hypertens Res. 41(12):989-990, 2018

2017年

  1. Itano S, Satoh M, Kadoya H, Sogawa Y, Uchida A, Sasaki T, Kashihara N. Colchicine attenuates renal fibrosis in a murine unilateral ureteral obstruction model. Mol Med Rep. 15(6):4169-75, 2017
  2. Nishimura H, Yaoita E, Nameta M, Yamaguchi K, Sato M, Ihoriya C, Zhao L, Kawachi H, Sasaki T, Ikezumi Y, Ouchi Y, Kashihara N, Yamamoto T. Restricted nutrition-induced low birth weight, low number of nephrons and glomerular mesangium injury in Japanese quail. J Dev Orig Health Dis. 8(3):287-300, 2017
  3. Tomita J, Mochizuki S, Fujimoto S, Kashihara N, Akasaka T, Tanimoto M, Yoshida K. Acute improvement of endothelial functions after oral ingestion of isohumulones, bitter components of beer. Biochem Biophys Res Commun. 484(4):740-5, 2017
  4. Nakamura K, Miura D, Saito Y, Yunoki K, Koyama Y, Satoh M, Kondo M, Osawa K, Hatipoglu OF, Miyoshi T, Yoshida M, Morita H, Ito H. Eicosapentaenoic acid prevents arterial calcification in klotho mutant mice. PLoS One.12(8);e0181009, 2017
  5. Sogawa Y, Nagasu H, Iwase S, Ihoriya C, Itano S, Uchida A, Kidokoro K, Taniguchi S, Takahashi M, Satoh M, Sasaki T, Suzuki T, Yamamoto M, Horng T, Kashihara N. Infiltration of M1, but not M2, macrophages is impaired after unilateral ureter obstruction in Nrf2-deficient mice. Sci Rep.7(1);8801,2017

受賞

2019年

第120回日本内科学会中国地方会　奨励賞　卜部恵莉子

2018年

2017年度臨床実習指導最優秀賞　腎臓高血圧内科学
2017年度臨床実習指導医優秀賞　山内　佑
第55回ヨーロッパ透析・移植学会　EIGHT BEST ABSTRACTS PRESENTED BY YOUNG AUTHORS　城所研吾
公益財団法人ウエスコ学術振興財団平成30年度学術研究費助成金　長洲　一
川崎医科大学附属病院　第一回治験実施優秀医師　腎臓内科担当医師
第18回川崎医学会研究奨励賞　十川裕史
第18回川崎医学会賞 川崎医学会誌論文賞　内田篤志
鈴木謙三記念医科学応用研究財団　平成30年度調査研究助成金　角谷裕之
第54回高血圧関連疾患モデル学会学術総会　会長賞　長洲　一
第9回腎不全研究会　会長賞　角谷裕之
Advans研究会2018　優秀AEA　十川裕史
Japan Kidney Council 2018　奨励賞　近藤　恵

2017年

第6回臨床高血圧フォーラム「若手活性化企画」全国高血圧治療チャンピオン大会優勝　十川　裕史、和田　佳久
平成29年度川崎医学・医療福祉学振興会地域連携・交流助成金　　　佐藤　稔
平成29年度川崎医学・医療福祉学振興会教育研究助成金　　　板野　精之
Japan Kidney Council 2017　優秀賞　　　十川　裕史